Blockade of Metallothioneins 1 and 2 Increases Skeletal Muscle Mass and Strength
Author(s) -
Serge Summermatter,
Anais Bouzan,
Eliane Pierrel,
Stefan Melly,
Daniela Stauffer,
Sabine Gutzwiller,
Erin Nolin,
Christina Dornelas,
Christy J. Fryer,
Juliet Leighton-Davies,
David J. Glass,
Brigitte Fournier
Publication year - 2016
Publication title -
molecular and cellular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.14
H-Index - 327
eISSN - 1067-8824
pISSN - 0270-7306
DOI - 10.1128/mcb.00305-16
Subject(s) - skeletal muscle , metallothionein , atrophy , blockade , biology , muscle atrophy , muscle hypertrophy , endocrinology , medicine , sarcopenia , myocyte , intracellular , anabolism , in vivo , microbiology and biotechnology , receptor , biochemistry , genetics , gene
Metallothioneins are proteins that are involved in intracellular zinc storage and transport. Their expression levels have been reported to be elevated in several settings of skeletal muscle atrophy. We therefore investigated the effect of metallothionein blockade on skeletal muscle anabolismin vitro andin vivo . We found that concomitant abrogation of metallothioneins 1 and 2 results in activation of the Akt pathway and increases in myotube size, in type IIb fiber hypertrophy, and ultimately in muscle strength. Importantly, the beneficial effects of metallothionein blockade on muscle mass and function was also observed in the setting of glucocorticoid addition, which is a strong atrophy-inducing stimulus. Given the blockade of atrophy and the preservation of strength in atrophy-inducing settings, these results suggest that blockade of metallothioneins 1 and 2 constitutes a promising approach for the treatment of conditions which result in muscle atrophy.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom